Anzeige
Mehr »
Dienstag, 30.06.2026 - Börsentäglich über 12.000 News
Direkt neben Europas erster Lithium-Mine: Wartet hier der nächste Börsengewinner
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 914998 | ISIN: BE0003766806 | Ticker-Symbol: IOB
Tradegate
30.06.26 | 21:24
17,000 Euro
-0,35 % -0,060
Branche
Sonstige Technologie
Aktienmarkt
BEL Mid
1-Jahres-Chart
ION BEAM APPLICATIONS SA Chart 1 Jahr
5-Tage-Chart
ION BEAM APPLICATIONS SA 5-Tage-Chart
RealtimeGeldBriefZeit
17,02017,08021:31
17,02017,08021:25

Aktuelle News zur ION BEAM APPLICATIONS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
07:06IBA SA: The National Proton Therapy Center of Portugal will be equipped with two IBA ProteusONE solutions4
DoIBA SA: IBA to install the first proton therapy center in Brazil in Rio de Janeiro985Louvain-La-Neuve, Belgium, June 25, 2026 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of proton therapy solutions...
► Artikel lesen
17.06.Ion Beam Applications: Aktie legt nach Managementumbau um 7 % zu21
17.06.IBA SA: IBA strengthens its Board with two high-profile appointments and announces the payment date of its dividend21
17.06.IBA SA: IBA strengthens its leadership team to support its growth407Olivier Legrain, CEO of IBA, is appointed Vice-Chairman of the IBA Board of Directors and Henri de Romrée, Deputy CEO, assumes strategic and operational responsibility for all Group activities. Catherine...
► Artikel lesen
10.06.IBA SA: IBA Announces Research Collaboration to Strengthen Evidence on the Value of Proton Therapy698Louvain-la-Neuve, Belgium, June 10, 2026 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the leading provider of proton therapy solutions for...
► Artikel lesen
ION BEAM APPLICATIONS Aktie jetzt für 0€ handeln
08.06.IBA SA: IBA signs contract with a major U.S. academic medical center to install two ProteusONE proton therapy solutions23
01.06.IBA SA: IBA launches Cyclone iKure, a cyclotron designed for industrial scale Astatine-211 production202Louvain-la-Neuve, Belgium - 01 June 2026 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the leading provider of radiopharmaceutical production...
► Artikel lesen
21.05.IBA SA: First quarter 2026 update: starting the year on track, with product innovation progress412Louvain-la-Neuve, Belgium, 21 May 2026 - IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, shares its business update for the first quarter of 2026. Group Overview...
► Artikel lesen
20.05.IBA SA: IBA launches Rhodotron LITE, a new low-power X-ray accelerator expanding access to sustainable irradiation solutions3
13.05.IBA SA: IBA introduces AdaPTinsight XR, the next generation of CBCT imaging for image-guided proton therapy6
06.05.IBA SA: IBA Introduces myQA StarTrack³ for Fast, High Resolution Linac QA with a Single Detector Setup9
24.04.IBA SA: The top 250 cancer specialists converge in Belgium to push the frontiers of proton therapy19
27.03.Ion Beam Applications SA Full Year Profit Advances39
27.03.Ion Beam Applications SA GAAP EPS of €0.43, revenue of €620.2M37
27.03.IBA SA: IBA delivers strong FY 2025 results with solid execution in all segments919Read the entire full-year 2025 results press release here Louvain-la-Neuve, Belgium, 27 March 2026 - IBA (Ion Beam Applications S.A.), today announces its consolidated results of 2025 financial year...
► Artikel lesen
21.03.IBA SA: IBA Launches myQAMatriXXAiR to Advance Patient-Specific QA in Particle Therapy1.238The first wireless ionization chamber array for particle therapy PSQA delivers fast, reliable verification for proton and carbon ion treatments, supporting emerging techniques such as FLASH and ARC...
► Artikel lesen
20.03.IBA SA: Telix selects IBA Cyclone KIUBE to support manufacturing expansion in the U.S.671Louvain-la-Neuve, Belgium- March 20, 2026 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of radiopharmaceutical...
► Artikel lesen
19.02.AKTIONÄR-Hot-Stock Ion Beam Applications: Nächster Auftrag - Aktie vor Kaufsignal923Das belgische Medizintechnik-Unternehmen ist ein wahrer Hidden Champion. Als Weltmarktführer in der Protonentherapie und intimer Kenner der gesamten radiopharmazeutischen Wertschöpfungskette dürfte...
► Artikel lesen
19.02.IBA SA: IBA and Shreeji sign multi-site agreement for four cyclotrons to expand PET radiopharmaceutical manufacturing across India877Louvain-la-Neuve, Belgium - 19 February 2026 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology with a preeminent position in nuclear medicine, and...
► Artikel lesen
Weiter >>
42 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1